Last update Nov. 13, 2024
Likely Compatibility
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
Anthralin, Dithranol is also known as
Anthralin, Dithranol in other languages or writings:
Anthralin, Dithranol belongs to this group or family:
Main tradenames from several countries containing Anthralin, Dithranol in its composition:
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by La Liga de la Leche, España of Spain
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Anthralin is a natural derivative of anthraquinone (tar), an antipsoriatic and anti-inflammatory agent. It is one of the first-line drugs in the treatment of psoriasis. Topical cutaneous administration.
At the date of the last update we found no published data on its excretion in breast milk.
Absorbed drug is excreted almost instantaneously through the kidneys, so plasma levels are very low or undetectable. (Hale, Goodfield 1994)
Given the possible mutagenic properties, infant skin should not come into contact with treated areas of maternal skin. It should not be applied to the breast so that the infant cannot ingest the product. (Gottlieb 2019)
Recommendations for Drugs in the Eleventh WHO Model List of Essential Drugs: compatible with Breastfeeding. (WHO 2002)